Velpanat is the first pan-genotypic (for all genotypes, 1 to 6) combination drug for the treatment of chronic viral hepatitis C with a regimen of 1 tablet per day.
Velpanat is the first pan-genotypic (for all genotypes, 1 to 6) combination drug for the treatment of chronic viral hepatitis C with a regimen of 1 tablet per day.